A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system

被引:132
作者
Schneider, A
Kuhn, HG
Schäbitz, WR
机构
[1] Axaron Biosci AG, D-69120 Heidelberg, Germany
[2] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Neurosci, Arvid Carlsson Inst Neurosci, S-40530 Gothenburg, Sweden
[3] Univ Munster, Dept Neurol, D-4400 Munster, Germany
关键词
G-CSF; stroke; cerebral ischemia; apoptosis; hematopoietic growth factor; neurogenesis; regeneration;
D O I
10.4161/cc.4.12.2213
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
G-CSF (Granulocyte-colony stimulating factor) is a hematopoietic growth factor that has been known for 20 years, and has been named for its role in the proliferation and differentiation of cells of the myeloic lineage. We have uncovered a novel spectrum of activities of G-CSF in the central nervous system. G-CSF and its receptor are expressed by neurons in many brain regions, and are upregulated upon experimental stroke. In neurons, G-CSF acts anti-apoptotically by activating several protective pathways. In vivo, G-CSF decreases infarct volumes in acute stroke models in rodents. Moreover, G-CSF stimulates neuronal differentiation of adult neural stem cells in the brain, and improves long-term recovery in more chronic stroke models. Thus, G-CSF is a novel neurotrophic factor, and a highly attractive candidate for the treatment of neurodegenerative conditions. Here we discuss this new property of G-CSF in contrast to its known functions in the hematopoietic system, summarize data from other groups on G-CSF's actions in cerebral ischemia, compare G-CSF to Erythropoietin (EPO) in the CNS, and highlight clinical implications.
引用
收藏
页码:1753 / 1757
页数:5
相关论文
共 59 条
[1]   Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes [J].
Alvarez-Dolado, M ;
Pardal, R ;
Garcia-Vardugo, JM ;
Fike, JR ;
Lee, HO ;
Pfeffer, K ;
Lois, C ;
Morrison, SJ ;
Alvarez-Buylla, A .
NATURE, 2003, 425 (6961) :968-973
[2]   Molecular analysis of the granulocyte colony-stimulating factor receptor [J].
Avalos, BR .
BLOOD, 1996, 88 (03) :761-777
[3]   ESTABLISHMENT AND CHARACTERISTICS OF A GASTRIC-CANCER CELL-LINE (HUGC-OOHIRA) PRODUCING HIGH-LEVELS OF G-CSF, GM-CSF, AND IL-6 - THE PRESENCE OF AUTOCRINE GROWTH-CONTROL BY G-CSF [J].
BABA, M ;
HASEGAWA, H ;
NAKAYABU, M ;
SHIMIZU, N ;
SUZUKI, S ;
KAMADA, N ;
TANI, K .
AMERICAN JOURNAL OF HEMATOLOGY, 1995, 49 (03) :207-215
[4]   Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa [J].
Banks, WA ;
Jumbe, NL ;
Farrell, CL ;
Niehoff, ML ;
Heatherington, AC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 505 (1-3) :93-101
[5]  
BEGLEY CG, 1986, BLOOD, V68, P162
[6]   Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-γ [J].
Boneberg, EM ;
Hareng, L ;
Gantner, F ;
Wendel, A ;
Hartung, T .
BLOOD, 2000, 95 (01) :270-276
[7]   Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor [J].
Brines, M ;
Grasso, G ;
Fiordaliso, F ;
Sfacteria, A ;
Ghezzi, P ;
Fratelli, M ;
Latini, R ;
Xie, QW ;
Smart, J ;
Su-Rick, CJ ;
Pobre, E ;
Diaz, D ;
Gomez, D ;
Hand, C ;
Coleman, T ;
Cerami, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (41) :14907-14912
[8]   Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury [J].
Brines, ML ;
Ghezzi, P ;
Keenan, S ;
Agnello, D ;
de Lanerolle, NC ;
Cerami, C ;
Itri, LM ;
Cerami, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10526-10531
[9]   Identification of the first invertebrate interleukin JAK/STAT receptor, the Drosophila gene domeless [J].
Brown, S ;
Hu, N ;
Hombría, JCG .
CURRENT BIOLOGY, 2001, 11 (21) :1700-1705
[10]   CHARACTERIZATION OF A SERUM FACTOR STIMULATING THE DIFFERENTIATION OF MYELOMONOCYTIC LEUKEMIC-CELLS [J].
BURGESS, AW ;
METCALF, D .
INTERNATIONAL JOURNAL OF CANCER, 1980, 26 (05) :647-654